Request Deal Involvement
Goldman Sachs Alternatives led a $105m Series B round in Attovia Therapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
or
Principals
bidder
CORMORANT ASSET MANAGEMENT
bidder
MARSHALL WACE
bidder
GOLDMAN SACHS ALTERNATIVES
target
ATTOVIA THERAPEUTICS
bidder
ILLUMINA VENTURES
bidder
NEXTECH
bidder
REDMILE GROUP
bidder
ECOR1 CAPITAL
bidder
LOGOS CAPITAL
bidder
VENBIO LLC
bidder
FRAZIER LIFE SCIENCES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite